Tag:
pertuzumab
Latest Headlines
Latest Headlines
FDA rewards Roche with priority review for blockbuster cancer drug
After racking up a solid set of late-stage data on the experimental breast cancer drug pertuzumab late last year, Roche ( $RHHBY ) and Genentech scored priority review status for the program, shaving
Roche, Novartis showcase game-changing breast cancer drug data
Roche and Novartis ( $NVS ) put out new data yesterday on two treatments that promise to fundamentally reshape the way the majority of breast cancer patients are treated. Roche clearly impressed
Roche preps full data on blockbuster hopeful for breast cancer
After the FDA dropped its breast cancer label on Avastin this month, Swiss pharma giant Roche could regain some steam in early December when it presents full data on its late-stage experimental
Roche gearing up to seek approvals of breast cancer treatment
Roche has its eyes on another cancer drug approval after the Swiss drug giant met the primary goal of a pivotal trial for a combination therapy against a form of breast cancer. Yet at least one
Genentech breathes new life into failed breast cancer drug
Genentech ( $DNA ) has found a new use for a failed drug. At the annual CTRC-AACR San Antonio Breast Cancer Symposium, the drugmaker revealed that pertuzumab and Herceptin in addition to chemotherapy
